Intervention Protocol

Intratympanic glucocorticoids for sudden sensorineural hearing loss

  1. Stefan K Plontke1,*,
  2. Christoph Meisner2,
  3. Per Caye-Thomasen3,
  4. Lorne Parnes4,
  5. Sumit Agrawal4,
  6. Tony Mikulec5

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008080

Database Title

Additional Information

How to Cite

Plontke SK, Meisner C, Caye-Thomasen P, Parnes L, Agrawal S, Mikulec T. Intratympanic glucocorticoids for sudden sensorineural hearing loss (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008080. DOI: 10.1002/14651858.CD008080.

Author Information

  1. 1

    University Hospital Tübingen, Department of Otorhinolaryngology, Head and Neck Surgery, Tübingen, Germany

  2. 2

    University Hospital Tübingen, Institute for Medical Biometry, Tübingen, Germany

  3. 3

    Gentofte University Hospital of Copenhagen, Department of Otorhinolaryngology Head and Neck Surgery, Hellerup, Denmark

  4. 4

    The University of Western Ontario, Department of Otolaryngology, London, Ontario, Canada

  5. 5

    St. Louis University, Department of Otolaryngology, St Louis, Missouri, USA

*Stefan K Plontke, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Tübingen, Tübingen Hearing Research Centre, Tübingen, D-72076, Germany. stefan.plontke@uni-tuebingen.de.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (148K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy, the effectiveness and the risks of adverse events of intratympanically applied glucocorticoids versus placebo therapy, versus no therapy or versus systemic application of glucocorticoids for treating unilateral sudden idiopathic sensorineural hearing loss, when given as a primary therapy or as a secondary (i.e. rescue or salvage) therapy after failure of systemic treatment.

View Full Article (HTML) Full (148K)